1. mAbDx awarded Small Business Innovative Research grant to develop a diagnostic test for Vibrio tubiashii, a bacterial shellfish pathogen that is a major problem for shellfish aquaculture

    Wed 01 October 2014

    mAbDx has been awarded a highly competitive Small Business Innovative Research (SBIR) grant from the United States Department of Agriculture, National Institute of Food and Agriculture (USDA, NIFA). The project goal is to develop an inexpensive diagnostic "dipstick" test for Vibrio tubiashii (Vt), a bacterial shellfish pathogen that causes serious ...

    read more
  2. mAbDx Chief Scientific Officer Michael Marusich, Ph.D., presents recent research to identify and characterize new mtDAMPs that drive the Systemic Inflammatory Response Syndrome (SIRS) after trauma

    Wed 11 September 2013

    mAbDx Chief Scientific Officer Michael Marusich, Ph.D., presented a research report titled “Defining the contribution of mitochondrial peptides to SIRS after tissue injury” at the 2013 Mérieux Research Grants Meeting, held in Annecy, France, Sept 11-13.  The work is a collaborative research project by Michael Marusich, Ph.D., mAbDx ...

    read more
  3. mAbDx moves into a new custom-built biotechnology laboratory in the recently completed Lewis Integrative Sciences Building on the University of Oregon campus

    Sun 01 September 2013

    mAbDx has relocated into private laboratory and office space in the newly completed Lewis Integrative Sciences Building on the campus of the University of Oregon.  The laboratory is designed for biotechnology research, in particular the development, characterization and validation of novel monoclonal antibodies and immunoassays.

    read more

« Page 2 / 5 »